Cogent Biosciences Provides 2022 Corporate Guidance

/PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Mastocytosis Adv ,Mastocytosis Nonadv ,Andrew Robbins ,John Robinson ,Cogent Research Team ,Virtual International Conference On Molecular ,Linkedin ,Cogent Biosciences Inc ,Twitter ,Prnewswire Cogent Biosciences Inc ,Nasdaq ,Advanced Systemic Mastocytosis ,Nonadvanced Systemic Mastocytosis ,Indolent Systemic Mastocytosis ,Smoldering Systemic Mastocytosis ,Gastrointestinal Stromal Tumors ,International Conference ,Molecular Targets ,Research Team ,Scientific Advisory Board ,Cogent Scientific Advisory Board ,Cogent Biosciences ,Nc ,